“…2 Only recently, however, have scientists begun to structurally characterize the active compounds and elucidate their molecular modes of action. Representative members of these families (Figure 1) include the phorbol esters, yuanhuapin, 3,4 gnidimacrin, 5 and rediocide A 6 which, along with many other family members, have emerged as significant therapeutic leads and research tools. 1 The phorbol esters, for example, are the most studied and potent tumor promoters known 7 while prostratin, 12-deoxy-phorbol 13-acetate, is a preclinical lead in studies directed at an as yet unattained but hugely important goal, the eradication of HIV/AIDS.…”